Anthropic 收购一人公司 Mithril Medicine，创始人 Cody Tranbarger 用 Claude 推进肌肉萎缩症药物研发
For six years, biotech Twitter knew him as Professor Oak. Now Cody Tranbarger has revealed his identity and announced that Anthropic acquired his one-person company, Mithril Medicine. As its only full-time employee, he worked with consultants and 11 outside labs, using Claude to help coordinate experiments, contracts, and data. According to Anthropic, the company reached promising mouse results for a potential muscular dystrophy treatment in under 18 months. Human trials could begin in late 2028 if development succeeds. His “Pipeline-in-a-Person” approach tests whether AI can help individual researchers oversee more drug programs and pursue rare diseases that often struggle for funding.
Anthropic 收购了 Cody Tranbarger 的一人公司 Mithril Medicine，他此前以 Professor Oak 的匿名身份活跃于生物科技圈六年。
一人公司用 Claude 协调 11 家外部实验室、18 个月内拿到小鼠结果，适合做热点评论拆解这套 AI 辅助研发流程。
粉丝 8.6万
The latest in AI and robotics, explained Founder & CEO of The Rundown AI Zurich 🇨🇭 / NYC 🇺🇸
- 浏览
- 2683
- 点赞
- 155
- 评论
- 1
- 分享
- 9
- 收藏
- 42
数字来自平台，为最近一次抓取时的数据。
以下是视频口播的自动转写，可能有错字。
So, the man behind this anonymous twitter account just sold his company to anthropic. But the plot twist was that his company was just him.
For six years, he posted under the name professor oak, and now he's revealed himself as cody tranbarger, founder of methrall medicine.
According to anthropic, he took a potential muscular dystrophy treatment from an idea to promising results in mice in under 18 months.
Cody calls his approach pipeline in a person, basically an ai assisted ecosystem where one person handles the entire r&d pipeline, managing experiments, data, and contracts across multiple outside laboratories with the help of an ai assistant, in his case, claude.
First, cody chose the scientific direction. Then he outsources experiments to 11 labs. So, to clarify, he was the company's only full time employee, but plenty of other humans were involved with the testing.
And lastly, he used claude to help connect everything, organizing contracts, coordinating experiments, and analyzing the results coming back.
And when you're working with 11 different labs, someone has to explain what each lab needs to do, chase down the results, and make sure everyone has what they need for the next experiment.
The more drugs are developing, the more time you spend keeping everyone on the same page. Cody's bet is that ai can absorb enough of that work for one scientist to oversee several programs simultaneously.
The treatment still needs human testing, potentially beginning in late 2028, if development succeeds. And now professor oak, or cody, is taking that same approach inside anthropic, where he plans to start more drug programs.
If you want to stay in the loop with the latest in ai and robotics, follow for more.
来源：TikTok · Rowan Cheung · tiktok.com